Source: Annual Congress 2005 - COPD - exacerbations I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. G. Franciosi, C. P. Page, B. R. Celli, M. Cazzola, M. J. Walker, M. Danhof, K. F. Rabe, O. E. Della Pasqua (Leiden, Netherlands; London, Greenford, United Kingdom; Boston, United States Of America; Naples, Italy; Vancouver, Canada). Evaluation of markers for exacerbations of COPD. Eur Respir J 2005; 26: Suppl. 49, 1896

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Management of COPD exacerbations Source: ERS Lung Science Conference 2019 Year: 2019 Modelling exacerbations of COPD Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present? Year: 2012 Predictors of exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Change in inflammation during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 15s Year: 2005 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Methodologies for study of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Acute exacerbations of COPD Source: Eur Respir Monogr 2016; 74: 48-65 Year: 2016 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Management of acute COPD exacerbations Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014